Senator Tom Coburn describes the future of Medicare reimbursements and comments on other issues of concern for physicians, such as tort reform and the individual mandate in the Affordable Care Act.
In a head-to-head trial, latanoprost was noninferior to timolol for treating glaucoma in children, according to a report in Ophthalmology online June 16. Reuters Health Information
On behalf of Mediphacos Ltda. (Belo Horizonte, Brazil), we would like to invite you to learn about Mediphacos’ new generation of acrylic IOLs, the MFR2, at the upcoming Pan-American Congress of Ophthalmology meeting in Buenos Aires, Argentina (7-9 July…
A British study of more than 100,000 patients suggests a link between thiazolidinedione (TZD) use and an increased incidence of diabetes-related macular edema. Medscape Medical News
According to the results of this head-to-head study published early online in Ophthalmology, latanoprost was non-inferior to timolol for the treatment of glaucoma in children.
The authors note that there ha…
BioSpace has reported on the 24-month results from the Phase III RIDE and RISE studies, which evaluated the efficacy and safety of ranibizumab (Lucentis) in the treatment of diabetic macular oedema (DMO). These fi…